Cellebrite DI Ltd. Selling and Marketing Expense
Cellebrite DI Ltd. (CLBT) reported Selling and Marketing Expense of $154.81 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-03-03
| Period end | Selling and Marketing Expense 6 month | Selling and Marketing Expense 12 month |
|---|---|---|
| 2025-12-31 | $154.81M 20-F · filed 2026-03-03 | |
| 2025-06-30 | $77.45M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $132.39M 20-F · filed 2026-03-03 | |
| 2024-06-30 | $64.38M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $110.81M 20-F · filed 2026-03-03 | |
| 2023-06-30 | $54.35M 6-K · filed 2024-08-15 | |
| 2022-12-31 | $97.39M 20-F · filed 2025-03-18 | |
| 2022-06-30 | $48.15M 6-K · filed 2023-09-01 | |
| 2021-12-31 | $76.39M 20-F · filed 2024-03-21 | |
| 2021-06-30 | $35.03M 6-K · filed 2022-09-13 | |
| 2020-12-31 | $61.30M 20-F · filed 2023-04-27 | |
| 2019-12-31 | $61.61M 20-F · filed 2022-03-29 |